Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications

Porvair Sciences reports on testing that demonstrates how its hydrophilic Vyon® porous plastics exhibit outstanding performance in drug discovery applications due to the high hydrophilic void volume conversion of the materials’ pore structure after a special treatment process.

Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications
Comparison of hydrophobic Vyon (Left) and the new hydrophilic Vyon porous polymer (Right).

Vyon® manufactured from HDPE (High Density Polyethylene) and & UHMWPE (Ultra-High Molecular Weight Polyethylene) is naturally hydrophobic and generally pose a significant level of difficulty for water and aqueous solutions to pass through or to be absorbed into the porous structure when required. Using a vacuum deposition process, the surface energy of Porvair’s manufactured Vyon® and its internal tortuous structure can be altered to promote hydrophilic characteristics and allow the material to wet out when in contact with water or other aqueous solutions. This allows the liquid to be effectively absorbed into the pore structure and opens up new possibilities for Vyon® to be effective in various applications including wicking and where the porous structure is required to act as a liquid reservoir with similar characteristics to a sponge.

Working in conjunction with an OEM partner – Porvair Sciences has been able to demonstrate that hydrophilic Vyon® is perfectly suited as a resin support media in the isolation and purification of pharmaceutical drug production. With excellent, consistent and uniform wetting performance and quick liquid absorption characteristics, hydrophilic Vyon® was shown to provide a strong and firm support with uniform liquid absorption and flow characteristics, a crucial prerequisite for drug discovery and purification processes.

For process chromatography applications, columns sizes may vary. For OEM partners – Porvair Science can manufacture tailored hydrophilic Vyon® discs to fit any column designs requiring hydrophilic discs of up to 2 m in diameter. These hydrophilic Vyon® disc supports are manufactured in a cGMP and temperature-controlled environment to achieve the tight tolerances required for most biomedical and life science applications.

To receive further information on hydrophilic Vyon® porous plastics or to discuss an application that could benefit from this novel high performance porous plastic please contact Porvair Sciences Ltd on +44-1978-661144 or [email protected]

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Porvair Sciences Limited. (2020, September 02). Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications. News-Medical. Retrieved on November 30, 2020 from https://www.news-medical.net/news/20200902/Hydrophilic-Vyonc2ae-plastics-demonstrate-outstanding-performance-for-drug-discovery-applications.aspx.

  • MLA

    Porvair Sciences Limited. "Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications". News-Medical. 30 November 2020. <https://www.news-medical.net/news/20200902/Hydrophilic-Vyonc2ae-plastics-demonstrate-outstanding-performance-for-drug-discovery-applications.aspx>.

  • Chicago

    Porvair Sciences Limited. "Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications". News-Medical. https://www.news-medical.net/news/20200902/Hydrophilic-Vyonc2ae-plastics-demonstrate-outstanding-performance-for-drug-discovery-applications.aspx. (accessed November 30, 2020).

  • Harvard

    Porvair Sciences Limited. 2020. Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications. News-Medical, viewed 30 November 2020, https://www.news-medical.net/news/20200902/Hydrophilic-Vyonc2ae-plastics-demonstrate-outstanding-performance-for-drug-discovery-applications.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
CEAT project for improving ovarian cancer diagnosis, treatment shows promise